LAS VEGAS — Cross-linking may have a role as an alternative to antimicrobial therapy for early infectious keratitis, according to research presented at the American Society of Cataract and Refractive Surgery meeting.
Emilio A. Torres-Netto, MD, PhD, and colleagues analyzed the time to corneal epithelialization using photoactivated chromophore for infectious keratitis cross-linking (PACK-CXL) as first-line treatment in early corneal ulcers compared with antimicrobials, the current standard of care.
The study comprised 23 patients in the medication group and 19 in the PACK-CXL group.